9/9/2002 6:03:00 AM
BOTHELL, Wash., Sep 9, 2002 (BUSINESS WIRE) — Microvision, Inc. (Nasdaq:MVIS),
the leader in light scanning technologies for personal displays and imaging
solutions, today announced that it has entered into a Technology Feasibility
Agreement with Ethicon Endo-Surgery, Inc., a Johnson & Johnson (NYSE:JNJ)
company located in Cincinnati, Ohio.
The Agreement is designed to advance certain medical applications utilizing
Microvision’s proprietary technology and to achieve initial proof-of-concept
milestones. Under the agreement, Ethicon may during this period elect to
exercise certain limited exclusive market rights to the technology under
development for up to 13 months. “We are pleased and proud to be working with
one of the world’s leading innovators of medical devices,” said Todd McIntyre,
Microvision vice president of business development. The agreement supports our
strategy of extending our proprietary micro mirror technology platform into
innovative high-value imaging and display applications that are also synergistic
with other product development initiatives at Microvision. We continue to
believe that our technology could have a truly significant impact in medical
imaging and displays.”
About Microvision
The company, located on the web at http://www.microvision.com, is headquartered
in Bothell, Washington. Microvision Inc. is the developer of the patented
retinal scanning display technology and a world leader in micro miniature
optical scanning technology for display and imaging applications. The company’s
technology has applications in a broad range of military, medical, industrial,
professional and consumer information products. Nomad is a trademark of
Microvision, Inc.
Forward Looking Statement
Certain statements contained in this release, including those concerning impact
in medical imaging and display and potential product applications are
forward-looking statements that involve a number of risks and uncertainties.
Factors that could cause actual results to differ materially from those
projected in our forward-looking statements include the following: market
acceptance of our technologies and products; our financial and technical
resources relative to those of our competitors; our ability to obtain financing;
our ability to keep up with rapid technological change; government regulation of
our technologies; our ability to enforce our intellectual property rights and
protect our proprietary technologies; the ability to obtain additional contract
awards and to develop partnership opportunities; the timing of commercial
product launches; the ability to achieve key technical milestones in key
products; and other risk factors identified from time to time in our SEC
reports, including in our Annual Report on 10-K for the year ended December 31,
2001 and our Quarterly Reports on Form 10-Q.
CONTACT:
Microvision, Inc.
Matt Nichols, 425/415-6657 (media)
Brian Heagler, 425/415-6794 (investors)
URL: http://www.businesswire.com
Copyright (C) 2002 Business Wire. All rights reserved.